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Clinics 
Age and sex: 56 years old male patient. 
Previous history: 
- no preleukemia; 
- no previous malignant disease; 
- no inborn condition of note. 
Organomegaly: 
- no hepatomegaly;  
- no splenomegaly;  
- no enlarged lymph node;  
- no central nervous system involvement 
Blood 
WBC: 213 x 109/l; Hb: 9.6 g/dl; platelets: 23 x 109/l; 
blasts: 93% 
Bone marrow: Markedly hypercellular, normal 
granulopoiesis depressed, near total replacement by 
blasts with high N/C ratio, agranular lightly basophilic 
cytoplasm, Poly 2, Lymp 4, Eos 1. PAS positive, SBB 
negative. 
Cytopathology classification 
Cytology: Acute lymphoblastic leukemia 
Immunophenotype: Positive for CD45, CD10, CD19, 
CD34, HLADR, TdT. 
Rearranged Ig or Tcr: - 
Pathology: - 
Electron microscopy: - 
Precise diagnosis: Acute lymphoblastic leukemia, L1 
(pre-B). 
Survival 
Date of diagnosis: 08-2006. 
Treatment: Methotrexate, Ara-C, Hyper-CVAD 
protocol. 
Complete remission was obtained. 
Treatment related death: -; 
Relapse: -; 
Phenotype at relapse: -; 
Status: Alive (04-2007); 
Survival: 9 months. 
Karyotype 
Sample: BM; Culture time: 24h; Banding: G-band. 
Results: 46,XY,der(16)t(1;16)(q11-12;q11) [20] 
Other molecular cytogenetic techniques: Fluorescence 
in situ hybridisation (FISH), with LSI CBFB DC and 
WCP probes for chromosome 1 and 16 (WPC DNA 
Probe 1, SpectrumOrange; WPC DNA Probe 16, 
SpectrumGreen) obtained from Vysis (Downers Grove 
IL, USA). 
Other molecular cytogenetics results : The analysis 
with LSI CBFB DC probe revealed one normal signal 
on the CBFB allele in the normal chromosome 16, 
while on the der(16) no red/green signal was detected, 
confirming the rearrangement of 16q. Hybridization 
with WCP 1 SpectrumOrange and WCP 16 
SpectrumGreen probes revealed 2 normal 
chromosomes 1, one normal chromosome 16 and 
confirmed the der(16)t(1;16). 
Other molecular studies 
Technics: RT-PCR for BCR-ABL  
Results: The BCR-ABL transcript was negative by the 
conventional method of molecular analysis. 
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Comments 
A 47-years old Filipino male was diagnosed with ALL 
in August 2006. Cytogenetic analysis of the bone 
marrow sample revealed a clearly abnormal 
chromosome 16 and the karyotype 46,XY,-
16,+der(16)t(1;16)(q11-12;q11) was identified in all 
the 30 examined metaphases. Recurrent whole-arm 
translocation of 1q to the centromeric region of 
chromosome 16 has been detected in a number of 
malignancies, but only occasionally described in 
hematological malignancies. The previously described 
3 MDS, 4 AML and 3 ALL cases with t(1;16)(q11-
q12;q11-12) were always unbalanced, suggesting either 
trisomy of 1q or monosomy of 16q may potentially 
contribute to leukemogenesis. 
 
Partial karyotypes demonstrating 2 normal chromosomes 1, one normal chromosome 16 and the der(16)t(1;16). C-banded 
chromosomes on the right side. 
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LSI CBFB DC, Break Apart Rearrangement Probe exhibiting one normal signal on the CBFB allele on normal chromosome 16. 
 
Whole chromosome painting showing 2 normal chromosomes 1 and the rearrangened chromosomes 1 and 16. 
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